HK1046913A1 - 為治療傳染病的被縮小微生物 - Google Patents

為治療傳染病的被縮小微生物

Info

Publication number
HK1046913A1
HK1046913A1 HK02107407.0A HK02107407A HK1046913A1 HK 1046913 A1 HK1046913 A1 HK 1046913A1 HK 02107407 A HK02107407 A HK 02107407A HK 1046913 A1 HK1046913 A1 HK 1046913A1
Authority
HK
Hong Kong
Prior art keywords
infection
treatment
attenuated microorganisms
attenuated
microorganisms
Prior art date
Application number
HK02107407.0A
Other languages
English (en)
Inventor
Dougan Gordon
William Holden David
David Santangelo Joseph
Elizabeth Shea Jacqueline
Richard Brennan Francis
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930456.0A external-priority patent/GB9930456D0/en
Priority claimed from GBGB9930461.0A external-priority patent/GB9930461D0/en
Priority claimed from GBGB9930458.6A external-priority patent/GB9930458D0/en
Priority claimed from GBGB9930460.2A external-priority patent/GB9930460D0/en
Priority claimed from GBGB9930455.2A external-priority patent/GB9930455D0/en
Priority claimed from GBGB9930459.4A external-priority patent/GB9930459D0/en
Priority claimed from GBGB9930457.8A external-priority patent/GB9930457D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of HK1046913A1 publication Critical patent/HK1046913A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02107407.0A 1999-12-23 2002-10-10 為治療傳染病的被縮小微生物 HK1046913A1 (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9930456.0A GB9930456D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930461.0A GB9930461D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930458.6A GB9930458D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930460.2A GB9930460D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930455.2A GB9930455D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930459.4A GB9930459D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930457.8A GB9930457D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
PCT/GB2000/005002 WO2001047962A2 (en) 1999-12-23 2000-12-22 Attenuated microorganisms for the treatment of infection

Publications (1)

Publication Number Publication Date
HK1046913A1 true HK1046913A1 (zh) 2003-01-30

Family

ID=27562965

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107407.0A HK1046913A1 (zh) 1999-12-23 2002-10-10 為治療傳染病的被縮小微生物

Country Status (17)

Country Link
US (1) US20030059442A1 (zh)
EP (1) EP1240192A2 (zh)
JP (1) JP2003518933A (zh)
KR (1) KR20020079755A (zh)
CN (1) CN1411468A (zh)
AP (1) AP2002002549A0 (zh)
AU (1) AU2210001A (zh)
BR (1) BR0016616A (zh)
CA (1) CA2395382A1 (zh)
CZ (1) CZ20022444A3 (zh)
EA (1) EA200200704A1 (zh)
HK (1) HK1046913A1 (zh)
HU (1) HUP0203646A2 (zh)
NO (1) NO20022949D0 (zh)
NZ (1) NZ519477A (zh)
OA (1) OA12130A (zh)
WO (1) WO2001047962A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640013A3 (en) * 2000-03-17 2007-02-21 Pharmacia & Upjohn Company LLC Inactivated Salmonella vaccines
ATE300949T1 (de) 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe
AU2001292035A1 (en) * 2000-09-29 2002-04-08 Microscience Limited Attenuated salmonella microorganisms comprising a mutation in the sifa gene
CA2678698A1 (en) * 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
CA2958892C (en) * 2014-08-29 2023-01-24 The Regents Of The University Of California Vaccine for livestock production systems
KR102424707B1 (ko) * 2020-10-12 2022-07-25 전북대학교산학협력단 표적단백질발현을 증가시킨 진핵세포질 내 다중항원발현용 재조합벡터 및 진핵세포 내 벡터전달시스템용 살모넬라 티피뮤리움의 조합 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines

Also Published As

Publication number Publication date
OA12130A (en) 2006-05-05
HUP0203646A2 (hu) 2003-03-28
AU2210001A (en) 2001-07-09
JP2003518933A (ja) 2003-06-17
NO20022949L (no) 2002-06-19
AP2002002549A0 (en) 2002-06-30
CZ20022444A3 (cs) 2002-10-16
WO2001047962A2 (en) 2001-07-05
US20030059442A1 (en) 2003-03-27
BR0016616A (pt) 2002-10-29
NO20022949D0 (no) 2002-06-19
EA200200704A1 (ru) 2003-08-28
CA2395382A1 (en) 2001-07-05
WO2001047962A3 (en) 2002-05-10
KR20020079755A (ko) 2002-10-19
WO2001047962A8 (en) 2002-10-31
CN1411468A (zh) 2003-04-16
EP1240192A2 (en) 2002-09-18
NZ519477A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
AP2001002317A0 (en) Attenuated microorganisms for the treatment of infection
HUP0203402A3 (en) Enzyme treatment for infection
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
ZA200007642B (en) Treatment of airborne microorganisms.
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
GB9925136D0 (en) Novel treatment
HUP0200738A3 (en) Method of the treatment of incontinence
IL144186A0 (en) Novel treatment
NZ513686A (en) Treatment of trauma
HK1046913A1 (zh) 為治療傳染病的被縮小微生物
GB9924087D0 (en) Treatment of process fluids
GB9906372D0 (en) Effluent treatment plant
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection
AU2003304316A8 (en) Compounds and methods for the treatment and prevention of bacterial infection
GB2350301B (en) Appliance for medical treatment
GB2359073B (en) Fluid treatment
IL152925A0 (en) Treatment of neuropathy
GB9924958D0 (en) Treatment of neuropathy
GB9924583D0 (en) Sludge treatment
SI1220858T1 (en) Oxazinoquinolones useful for the treatment of viral infections
GB9923111D0 (en) Effluent treatment
ZA200204801B (en) Method of inactivating microorganisms.
GB9920788D0 (en) Novel treatment
GB9909650D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment